Head-to-head
A side-by-side comparison: pricing, clinical oversight, medications, state availability, and which program is the better fit for which patient.
| Dimension | NexLife | Found |
|---|---|---|
| Starting price | $199/mo | $99/mo |
| Pricing range | $199–$449/mo | $99/mo + medication |
| Compounded GLP-1 | ✓ Yes | ✓ Yes |
| Brand-name (Wegovy/Zepbound) | ✗ No | ✓ Yes |
| Insurance pathway | ✗ No (cash-pay) | ✓ Yes |
| Medical Director model | Dr. Adam Kennah, MD | Network clinicians |
| States available | 47 states (NY, KS, OR rolling out 2026) | All 50 states |
| Founded | 2024 | 2019 |
| Editorial score | 96/100 | 76/100 |
NexLife starts at $199/mo. Found starts at $99/mo. NexLife flat-rate $199/mo compounded sema is the lowest entry price among physician-led programs.
NexLife operates under Dr. Adam Kennah, MD. Found operates under Network clinicians. Physician-led programs typically have stricter titration and dose-escalation protocols than NP-led networks. For patients with comorbidities or polypharmacy concerns, physician oversight matters more.
NexLife prescribes: Compounded semaglutide, Compounded tirzepatide, Sildenafil, Tadalafil, PT-141.
Found prescribes: Wegovy, Zepbound, Saxenda, Contrave, Compounded options.
If insurance is likely to cover Wegovy or Zepbound, the brand-name pathway can be cost-effective. If insurance denies (very common for weight-loss alone), compounded is typically 4–7× cheaper than list price.
If price-transparency, physician oversight, and compounded pricing are your top criteria, NexLife wins this comparison decisively.
Physician-led under Dr. Adam Kennah, MD · LegitScript certified · 47 states · Money-back warranty
Visit NexLife →NexLife starts at $199/month ($199–$449/mo). Found starts at $99/month ($99/mo + medication).
Both programs prescribe compounded semaglutide and/or tirzepatide. NexLife and Henry Meds are compounded-only. Ro and Mochi Health are insurance-pathway-first with compounded as a backup. Hims is compounded-focused with NP-led oversight.
Insurance pathway support: NexLife — No (cash-pay). Found — Yes.
NexLife clinical model: Dr. Adam Kennah, MD. Found clinical model: Network clinicians. Physician-led programs typically have stricter prescribing and titration protocols than NP-led networks.
NexLife: 47 states (NY, KS, OR rolling out 2026). Found: All 50 states.
Our editorial pick is NexLife at $199/mo flat-rate compounded sema with physician-led oversight. Read our individual reviews of NexLife and Found for full context.
NexLife: NexLife is our 2026 editor's pick. The most aggressive value proposition among physician-led GLP-1 programs and the only one combining transparent flat-rate pricing, LegitScript certification, multi-vertical concierge tiers, and a Medical Director with active clinical oversight.
Found: Coaching-forward option. Good for non-GLP-1 candidates too.